Dexcom (DXCM) Other Operating Expenses (2010 - 2022)

Dexcom (DXCM) has reported Other Operating Expenses for 7 consecutive years, with -$5.7 million the latest figure, recorded in Q4 2022.

• On a quarterly basis, Other Operating Expenses fell 106.72% year-over-year to -$5.7 million in Q4 2022; TTM through Sep 2023 was -$5.7 million, a 106.3% decrease from a year earlier, with the FY2021 full-year figure at $87.1 million, up 3384.0% from the prior year.
• Other Operating Expenses was -$5.7 million for Q4 2022 at Dexcom, down from $1.8 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $217.7 million in Q4 2018 and troughed at -$5.7 million in Q4 2022.
• A 5-year average of $30.7 million and a median of $1.8 million in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses surged 4194304000000100.0% in 2020 and plunged 106.72% in 2022, its largest moves.
• Over 5 years, Other Operating Expenses stood at $217.7 million in 2018, then tumbled by 100.0% to -$0.0 in 2019, then surged by 4194304000000100.0% to $2.5 million in 2020, then jumped by 3292.0% to $84.8 million in 2021, then sank by 106.72% to -$5.7 million in 2022.
• The last three Other Operating Expenses figures came in at -$5.7 million (Q4 2022), $1.8 million (Q3 2022), and $1.9 million (Q2 2022), per Business Quant data.